In 1995, Bausch + Lomb collaborated for a clinical trial with government researchers at the National Eye Institute. The goal: To see if a high dose nutrient formula can help people with Age-related Macular Degeneration.
NEI researchers concluded their first
five-year clinical Age Related Eye Disease
Study participants ages 55
to 80 years, with and
Reduced risk of moderate
vision loss after five years.
Reduction in risk of AMD
progression in those with
moderate to advanced
continued effects at
study follow-up in 2006.
Based on new learnings around AMD, the
NEI researchers sought to improve the
original AREDS formula.
The result was an updated formula that replaced beta-carotene with lutein and zeaxanthin, since new research suggested an association between beta-carotene and an increase in the risk of lung cancer among those with a history of smoking.2
Study participants ages 50
to 85, with AMD.
Clinical centers across the
Length of AREDS2 study.
Reduced risk of
progressing to advanced
AMD, compared to
patients taking the
1. No clinically statistically significant differences in AEs between treatment groups. Post-hoc subgroup analysis
2. Johnson EJ. Curr Opin Clin Nutr Metab Care. 2010;13(1):28-33
The NEI recommends taking a vitamin formula that contains the exact nutrients based on the AREDS2 study for helping to reduce the risk of progression in moderate to advanced AMD.
* Percent Daily Values (DV) Based on a 2000-calorie diet
**Daily value not established
The National Eye Institute is working on its report on the AREDS2 10-year
follow-up study, and the results will be announced.
No clinically or statistically significant AEs between treatment groups,1 but eliminating beta-carotene was associated with reduced risk of lung cancer in patients with a history of smoking (P=.04).2
No side effects were observed in patients who received a formula with 80 mg zinc per day.
No significant correlation was established for EPA + DHA supplementation with the progression of AMD.
This link takes you to a 3rd party site to compare prices, check availability and/or purchase products.
This website is not affiliated with Bausch + Lomb.
Bausch + Lomb is not responsible for the content, maintenance, or policies of the website you are about to enter, and does not monitor non-affiliated websites for accuracy.
*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease.
†Compared to original PreserVision® AREDS 2 Soft Gel
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
AREDS and AREDS2 are registered trademarks of the United States
Department of Health and Human Services (HHS).
All information and materials on this site pertain to the U.S. only, unless
© 2020 Bausch & Lomb Incorporated or its affiliates. PVN.0099.USA.19
CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION